Annual Shareholders Equity
$14.11 M
-$7.71 M-35.34%
31 December 2023
Summary:
AcelRx Pharmaceuticals annual stockholders equity is currently $14.11 million, with the most recent change of -$7.71 million (-35.34%) on 31 December 2023. During the last 3 years, it has risen by +$50.00 million (+139.30%).ACRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$14.11 M
-$4.20 M-22.95%
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly stockholders equity is currently $14.11 million, with the most recent change of -$4.20 million (-22.95%) on 31 December 2023.ACRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +139.3% | +139.3% |
| 5 y5 years | +134.1% | +134.1% |
ACRX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -80.7% | -80.7% |
AcelRx Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $14.11 M(-35.3%) | $14.11 M(-23.0%) |
| Sept 2023 | - | $18.31 M(+75.7%) |
| June 2023 | - | $10.42 M(-26.8%) |
| Mar 2023 | - | $14.24 M(-34.7%) |
| Dec 2022 | $21.81 M(-160.8%) | $21.81 M(-20.8%) |
| Sept 2022 | - | $27.54 M(-16.9%) |
| June 2022 | - | $33.14 M(-186.6%) |
| Mar 2022 | - | -$38.27 M(+6.6%) |
| Dec 2021 | -$35.89 M(-35.6%) | -$35.89 M(-16.6%) |
| Sept 2021 | - | -$43.02 M(+19.5%) |
| June 2021 | - | -$35.99 M(+31.8%) |
| Mar 2021 | - | -$27.31 M(-51.0%) |
| Dec 2020 | -$55.75 M(+34.6%) | -$55.75 M(-3.6%) |
| Sept 2020 | - | -$57.85 M(-3.8%) |
| June 2020 | - | -$60.13 M(+8.8%) |
| Mar 2020 | - | -$55.28 M(+33.5%) |
| Dec 2019 | -$41.42 M(-1073.9%) | -$41.42 M(+46.5%) |
| Sept 2019 | - | -$28.27 M(+53.5%) |
| June 2019 | - | -$18.42 M(+133.4%) |
| Mar 2019 | - | -$7.89 M(-285.5%) |
| Dec 2018 | $4.25 M(-111.6%) | $4.25 M(-111.3%) |
| Sept 2018 | - | -$37.79 M(-22.8%) |
| June 2018 | - | -$48.97 M(+4.4%) |
| Mar 2018 | - | -$46.88 M(+28.4%) |
| Dec 2017 | -$36.51 M(+584.1%) | -$36.51 M(+20.5%) |
| Sept 2017 | - | -$30.31 M(-4.2%) |
| June 2017 | - | -$31.62 M(+60.9%) |
| Mar 2017 | - | -$19.66 M(+268.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | -$5.34 M(-116.1%) | -$5.34 M(-263.1%) |
| Sept 2016 | - | $3.27 M(-75.8%) |
| June 2016 | - | $13.50 M(-42.4%) |
| Mar 2016 | - | $23.44 M(-29.2%) |
| Dec 2015 | $33.11 M(-29.0%) | $33.11 M(-17.1%) |
| Sept 2015 | - | $39.97 M(+19.7%) |
| June 2015 | - | $33.39 M(-18.7%) |
| Mar 2015 | - | $41.09 M(-11.9%) |
| Dec 2014 | $46.66 M(-36.2%) | $46.66 M(-21.0%) |
| Sept 2014 | - | $59.08 M(+6.4%) |
| June 2014 | - | $55.55 M(-14.6%) |
| Mar 2014 | - | $65.06 M(-11.1%) |
| Dec 2013 | $73.16 M(+116.1%) | $73.16 M(+37.5%) |
| Sept 2013 | - | $53.20 M(+780.7%) |
| June 2013 | - | $6.04 M(-72.4%) |
| Mar 2013 | - | $21.92 M(-35.2%) |
| Dec 2012 | $33.85 M(+93.8%) | $33.85 M(<-9900.0%) |
| Sept 2012 | - | -$327.00 K(-104.3%) |
| June 2012 | - | $7.63 M(-30.8%) |
| Mar 2012 | - | $11.03 M(-36.9%) |
| Dec 2011 | $17.47 M(-126.5%) | $17.47 M(-25.2%) |
| Sept 2011 | - | $23.36 M(-17.8%) |
| June 2011 | - | $28.41 M(-11.1%) |
| Mar 2011 | - | $31.96 M(-148.5%) |
| Dec 2010 | -$65.89 M(+24.3%) | -$65.89 M(-3024.6%) |
| Sept 2010 | - | $2.25 M(-104.3%) |
| Dec 2009 | -$52.99 M(+59.0%) | -$52.99 M |
| Dec 2008 | -$33.34 M | - |
FAQ
- What is AcelRx Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for AcelRx Pharmaceuticals?
What is AcelRx Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ACRX is $14.11 M
What is the all time high annual shareholders equity for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual stockholders equity is $73.16 M
What is AcelRx Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ACRX is $14.11 M
What is the all time high quarterly shareholders equity for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly stockholders equity is $73.16 M